NCT02610062 2024-11-01A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)Astellas Pharma IncPhase 1 Terminated23 enrolled